908 Devices (MASS) just posted its latest FY 2025 numbers with Q3 revenue of US$14.0 million and a basic EPS loss of US$0.41, keeping profitability under pressure despite a full year of reported trading. The company has seen revenue move from US$11.5 million in Q2 2024 to US$18.8 million in Q4 2024, then settle at US$11.8 million, US$13.0 million and US$14.0 million through the first three quarters of 2025, while quarterly basic EPS losses ranged between US$0.22 and US$0.68 over that period. For investors, the focus is on how efficiently that revenue is being converted, with persistent losses keeping margins front and center as you evaluate what this latest release implies.

See our full analysis for 908 Devices.

With the headline numbers on the table, the next step is to see how this earnings profile lines up with the most common narratives around 908 Devices, and where those stories might need updating.

Losses remain heavy despite US$65 million in trailing revenue

• Over the last twelve months, 908 Devices generated US$65.0 million of revenue while posting a net loss from continuing operations of US$72.7 million and a trailing basic EPS loss of US$2.05, so the company is still spending more than it brings in.
• Bulls point to growing exposure to healthcare, bioprocessing, and law enforcement as a way to build recurring revenue and eventually narrow those losses. However, the trailing figures keep that optimism in check:
  • Recurring revenue now accounts for more than one third of total sales in the bullish narrative, but the last twelve months still produced a US$72.7 million loss from continuing operations, so the earnings drag is significant even with that mix shift.
  • Supporters highlight software, automation, and AI analytics as levers for better margins, although the trailing EPS loss of US$2.05 per share shows that any margin gains so far have not translated into profitability.

Bulls argue that these losses are the price of building a larger installed base, but the current income statement shows how much patience that requires. 🐂 908 Devices Bull Case

Five year earnings decline of 30.3% backs the cautious view

• Over the past five years, earnings have fallen at an annualized rate of 30.3%, and the company is not expected to be profitable within the next three years, which keeps the focus firmly on whether the current business model can absorb its cost base.
• Bears highlight the combination of shrinking earnings and reliance on a narrow product set as a key concern, and the reported numbers support several of those points:
  • Recent quarterly net losses from continuing operations of US$9.8 million, US$12.9 million and US$14.9 million in Q1, Q2 and Q3 2025 line up with the idea that profitability has not improved in step with revenue moving from US$11.8 million to US$14.0 million.
  • Critics also point to exposure to government and grant funded customers, and the absence of a forecast path to profitability within three years reinforces that these buyers have not yet produced enough high margin volume to offset the cost structure.

For a cautious investor, that 30.3% multi year earnings decline is a concrete signal to focus on the durability of losses rather than only on revenue traction. 🐻 908 Devices Bear Case

DCF fair value at US$18.19 versus US$6.32 share price

• The current share price of US$6.32 sits well below both the DCF fair value of US$18.19 and the analysts' consensus price target of US$10.00, while the 3.5x P/S multiple is higher than the US Electronic industry average of 2.7x but lower than the 7.1x peer average.
• Consensus narrative suggests there could be long term upside if margins improve. However, the present loss profile means the valuation gap cuts both ways:
  • On one side, trading about 65% below the DCF fair value and below the peer group P/S multiple may appeal to investors who think the current US$72.7 million trailing loss can narrow meaningfully over time.
  • On the other side, the same data set shows no expectation of profitability within three years, so the market price of US$6.32 may simply be reflecting that near term earnings risk despite the higher DCF fair value and US$10.00 target.

Next Steps

To see how these results tie into long-term growth, risks, and valuation, check out the full range of community narratives for 908 Devices on Simply Wall St. Add the company to your watchlist or portfolio so you'll be alerted when the story evolves.

If this mix of risks and potential rewards leaves you undecided, it is worth looking through the full data set yourself and forming a view quickly, starting with 1 key reward and 2 important warning signs.

See What Else Is Out There

With multi year earnings declining 30.3% and continued net losses despite US$65.0 million in trailing revenue, 908 Devices is still wrestling with profitability.

If that kind of ongoing loss profile feels a bit too intense, you might want to quickly scan 75 resilient stocks with low risk scores and focus on companies with more resilient risk scores.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.